Organon & Co | OGN - Trade Creditors


Organon & Co reported $982M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Celltrion KRW 89.12B 534.9M Jun/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 5.5M 892K Sep/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
Gilead Sciences USD 934M 260M Sep/2026
Glaxosmithkline GBP 15.63B 1.3B Sep/2026
Kangmei Pharma CNY 2.27B 185.33M Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Merck USD 5.03B 1.2B Sep/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Novartis USD 4.24B 79M Sep/2026
Organigram Holdings CAD 99.93M 26.79M Jun/2026
Organon & Co USD 982M 69M Sep/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 50.62M 11.69M Sep/2026
Qiagen NV USD 79.08M 785K Jun/2026
Sartorius EUR 324.8M 4.3M Sep/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tilray USD 114.5M 3.69M Sep/2025
Zealand Pharma A/S 171M 175.6M Mar/2026